Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
NCT05131594 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-09-19
Summary
Many people who have had COVID 19 continue to experience symptoms long after they have recovered from the acute infection. This study will examine the clinical symptoms of people with "Long COVID" and measure various markers of inflammation in their blood.
Conditions
Sponsors & Collaborators
-
San Diego Biomedical Research Institute
collaborator OTHER -
Huntington Memorial Hospital
lead OTHER
Principal Investigators
-
Kimberly Shriner, MD · Huntington Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-13
- Primary Completion
- 2025-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2
NCT04655521 ·Status: COMPLETED
-
COVID-19 Immune Repertoire Sequencing
NCT04368143 ·Status: COMPLETED
-
Inflammatory Responses in Normal Volunteers and Patients With Abnormal Immune Responses
NCT00001257 ·Status: TERMINATED
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Antibodies Responses to COVID-19 Infection in Hospitalized Patients
NCT04520880 ·Status: UNKNOWN
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
COVID-19 Antibody and Reinfection Study
NCT05365750 ·Status: COMPLETED
-
Biomarkers for Post-COVID Conditions
NCT05196516 ·Status: COMPLETED
-
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
NCT04543006 ·Status: UNKNOWN ·Phase: NA
-
International Study of Inflammation in COVID-19
NCT04818866 ·Status: COMPLETED
-
Profiling the Inflammatory Cascade of COVID-19
NCT06511024 ·Status: COMPLETED
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection
NCT05242159 ·Status: UNKNOWN
-
Neutralizing Antibody Level After COVID-19 Vaccination
NCT05083026 ·Status: RECRUITING
-
Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways
NCT06971289 ·Status: NOT_YET_RECRUITING
-
Evaluation of Patients With Immune Function Abnormalities
NCT00128973 ·Status: RECRUITING
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease
NCT05812612 ·Status: UNKNOWN
-
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
NCT07251179 ·Status: NOT_YET_RECRUITING
-
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002 ·Status: RECRUITING
-
Autoimmunity Contributes to the Severe Progression of COVID-19
NCT04967781 ·Status: COMPLETED
-
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
NCT04562285 ·Status: COMPLETED
-
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
NCT06587828 ·Status: RECRUITING
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING